ORTOMA AB B (82Y) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ORTOMA AB B (82Y) has a cash flow conversion efficiency ratio of -0.120x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.13 Million ≈ $-20.03 Million USD) by net assets (€142.72 Million ≈ $166.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ORTOMA AB B - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how ORTOMA AB B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 82Y total liabilities for a breakdown of total debt and financial obligations.
ORTOMA AB B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ORTOMA AB B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HeraMED Limited
F:1I4
|
-0.309x |
|
ABVC Biopharma Inc
NASDAQ:ABVC
|
-0.044x |
|
Vibhor Steel Tubes Limited
NSE:VSTL
|
N/A |
|
Plantynet Co. Ltd
KQ:075130
|
0.028x |
|
Reka Industrial Oyj
HE:REKA
|
0.024x |
|
Investcorp Credit Management BDC Inc
NASDAQ:ICMB
|
-0.076x |
|
Mundoro Capital Inc
V:MUN
|
0.111x |
|
Armidian Karyatama Tbk PT
JK:ARMY
|
0.014x |
Annual Cash Flow Conversion Efficiency for ORTOMA AB B (2021–2025)
The table below shows the annual cash flow conversion efficiency of ORTOMA AB B from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see ORTOMA AB B market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €142.72 Million ≈ $166.85 Million |
€6.04 Million ≈ $7.06 Million |
0.042x | +131.12% |
| 2024-12-31 | €161.91 Million ≈ $189.29 Million |
€-22.01 Million ≈ $-25.73 Million |
-0.136x | -276.65% |
| 2023-12-31 | €173.54 Million ≈ $202.88 Million |
€13.35 Million ≈ $15.61 Million |
0.077x | +206.13% |
| 2022-12-31 | €114.29 Million ≈ $133.62 Million |
€-8.29 Million ≈ $-9.69 Million |
-0.073x | +37.94% |
| 2021-12-31 | €130.04 Million ≈ $152.03 Million |
€-15.19 Million ≈ $-17.76 Million |
-0.117x | -- |
About ORTOMA AB B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more